Quidel Corporation Company Profile (NASDAQ:QDEL)

About Quidel Corporation (NASDAQ:QDEL)

Quidel Corporation logoQuidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Supplies
  • Symbol: NASDAQ:QDEL
  • CUSIP: 74838J10
  • Web: www.quidel.com
Capitalization:
  • Market Cap: $914.47 million
  • Outstanding Shares: 33,205,000
Average Prices:
  • 50 Day Moving Avg: $25.10
  • 200 Day Moving Avg: $22.32
  • 52 Week Range: $16.63 - $27.94
P/E:
  • Trailing P/E Ratio: 226.33
  • Foreward P/E Ratio: 57.38
  • P/E Growth: 2.98
Sales & Book Value:
  • Annual Revenue: $214.97 million
  • Price / Sales: 4.25
  • Book Value: $6.63 per share
  • Price / Book: 4.15
Profitability:
  • EBIDTA: $39.8 million
  • Net Margins: 1.83%
  • Return on Equity: 1.94%
  • Return on Assets: 1.02%
Debt:
  • Debt-to-Equity Ratio: 0.68%
  • Current Ratio: 8.41%
  • Quick Ratio: 7.64%
Misc:
  • Average Volume: 177,673 shs.
  • Beta: 1.23
  • Short Ratio: 18.27
 

Frequently Asked Questions for Quidel Corporation (NASDAQ:QDEL)

What is Quidel Corporation's stock symbol?

Quidel Corporation trades on the NASDAQ under the ticker symbol "QDEL."

How were Quidel Corporation's earnings last quarter?

Quidel Corporation (NASDAQ:QDEL) released its quarterly earnings data on Monday, April, 24th. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.15 by $0.30. The firm earned $73.70 million during the quarter, compared to the consensus estimate of $61.85 million. Quidel Corporation had a return on equity of 1.94% and a net margin of 1.83%. The company's quarterly revenue was up 46.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.02 earnings per share. View Quidel Corporation's Earnings History.

When will Quidel Corporation make its next earnings announcement?

Quidel Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, July, 25th 2017. View Earnings Estimates for Quidel Corporation.

Where is Quidel Corporation's stock going? Where will Quidel Corporation's stock price be in 2017?

4 analysts have issued 1-year price targets for Quidel Corporation's shares. Their predictions range from $22.00 to $27.00. On average, they expect Quidel Corporation's stock price to reach $24.67 in the next year. View Analyst Ratings for Quidel Corporation.

Who are some of Quidel Corporation's key competitors?

Who are Quidel Corporation's key executives?

Quidel Corporation's management team includes the folowing people:

  • Kenneth F. Buechler Ph.D., Chairman of the Board
  • Douglas C. Bryant, President, Chief Executive Officer, Director
  • Randall J. Steward, Chief Financial Officer
  • Robert Joseph Bujarski J.D., Senior Vice President - Business Development, General Counsel and Corporate Secretary
  • Michael D. Abney Jr., Senior Vice President - Distribution
  • Werner Kroll Ph.D, Senior Vice President,R&D
  • Edward Keith Russell, Senior Vice President - Global Commercial Operations
  • John D. Tamerius Ph.D., Senior Vice President - Strategic and External Affairs
  • Charles P. Slacik CPA, Director
  • Thomas D. Brown, Independent Director

Who owns Quidel Corporation stock?

Quidel Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include Brown Capital Management LLC (17.46%), Oracle Investment Management Inc. (7.58%), Vanguard Group Inc. (6.45%), Macquarie Group Ltd. (3.60%), Janus Capital Management LLC (3.44%) and Dimensional Fund Advisors LP (2.57%). Company insiders that own Quidel Corporation stock include Douglas C Bryant, John Tamerius and Robert Joseph Bujarski. View Institutional Ownership Trends for Quidel Corporation.

Who sold Quidel Corporation stock? Who is selling Quidel Corporation stock?

Quidel Corporation's stock was sold by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Renaissance Technologies LLC, Baird Financial Group Inc., Credit Suisse AG, Parametric Portfolio Associates LLC, Dimensional Fund Advisors LP, TIAA CREF Investment Management LLC and California Public Employees Retirement System. Company insiders that have sold Quidel Corporation stock in the last year include Douglas C Bryant, John Tamerius and Robert Joseph Bujarski. View Insider Buying and Selling for Quidel Corporation.

Who bought Quidel Corporation stock? Who is buying Quidel Corporation stock?

Quidel Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Macquarie Group Ltd., Vanguard Group Inc., Sei Investments Co., MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Trexquant Investment LP and Investment Management of Virginia LLC. View Insider Buying and Selling for Quidel Corporation.

How do I buy Quidel Corporation stock?

Shares of Quidel Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quidel Corporation's stock price today?

One share of Quidel Corporation stock can currently be purchased for approximately $27.54.


MarketBeat Community Rating for Quidel Corporation (NASDAQ QDEL)
Community Ranking:  2.2 out of 5 ( )
Outperform Votes:  118 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  263
MarketBeat's community ratings are surveys of what our community members think about Quidel Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Quidel Corporation (NASDAQ:QDEL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $24.67 (10.43% downside)

Analysts' Ratings History for Quidel Corporation (NASDAQ:QDEL)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/19/2017Canaccord GenuityReiterated RatingHold$24.50 -> $25.00LowView Rating Details
4/26/2017Barclays PLCBoost Price TargetOverweight$26.00 -> $27.00LowView Rating Details
2/17/2017CL KingInitiated CoverageNeutralN/AView Rating Details
12/16/2016Piper Jaffray CompaniesDowngradeOverweight -> Neutral$22.00N/AView Rating Details
6/13/2016Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$21.50N/AView Rating Details
2/18/2016Craig HallumLower Price TargetHold$18.00 -> $16.00N/AView Rating Details
1/8/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 6/28/2015 forward)

Earnings

Earnings History for Quidel Corporation (NASDAQ:QDEL)
Earnings by Quarter for Quidel Corporation (NASDAQ:QDEL)
Earnings History by Quarter for Quidel Corporation (NASDAQ QDEL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2017        
4/24/2017Q1 2017$0.15$0.45$61.85 million$73.70 millionViewN/AView Earnings Details
2/8/2017Q416$0.02$0.17$58.42 million$52.80 millionViewListenView Earnings Details
10/26/2016Q316($0.02)$0.10$50.88 million$49.30 millionViewListenView Earnings Details
7/27/2016Q216($0.25)($0.11)$37.98 million$39.10 millionViewListenView Earnings Details
4/27/2016Q116($0.07)$0.02$49.21 million$50.30 millionViewListenView Earnings Details
2/17/2016Q415$0.05$0.10$54.01 million$52.40 millionViewListenView Earnings Details
10/28/2015Q315($0.14)$0.05$43.48 million$46.80 millionViewListenView Earnings Details
7/22/2015Q215($0.25)($0.14)$34.17 million$34.87 millionViewListenView Earnings Details
4/23/2015Q115$0.12$0.30$61.22 million$61.30 millionViewListenView Earnings Details
2/11/2015Q414$0.10$0.37$60.61 million$63.60 millionViewListenView Earnings Details
10/21/2014Q314($0.12)($0.01)$37.80 million$40.90 millionViewListenView Earnings Details
7/22/2014Q214($0.16)($0.10)$31.90 million$31.50 millionViewListenView Earnings Details
4/23/2014Q114$0.30$0.08$63.26 million$46.70 millionViewListenView Earnings Details
2/11/2014Q413$0.09$0.20$48.67 million$50.00 millionViewListenView Earnings Details
10/23/2013Q313($0.07)($0.02)$37.32 million$33.50 millionViewListenView Earnings Details
7/30/2013Q2 2013($0.11)($0.06)$33.24 million$29.71 millionViewListenView Earnings Details
4/23/2013Q1 2013$0.46$0.49$62.63 million$61.99 millionViewN/AView Earnings Details
2/12/2013Q4 2012$0.29$0.26$53.30 million$53.93 millionViewListenView Earnings Details
10/23/2012($0.03)$0.08ViewN/AView Earnings Details
7/25/2012($0.08)$0.01ViewN/AView Earnings Details
2/29/2012$0.06$0.15ViewN/AView Earnings Details
10/25/2011($0.06)($0.03)ViewN/AView Earnings Details
8/2/2011($0.07)($0.04)ViewN/AView Earnings Details
4/28/2011$0.33$0.35ViewN/AView Earnings Details
2/24/2011($0.01)$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Quidel Corporation (NASDAQ:QDEL)
Current Year EPS Consensus Estimate: $0.46 EPS
Next Year EPS Consensus Estimate: $0.48 EPS

Dividends

Dividend History for Quidel Corporation (NASDAQ:QDEL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Quidel Corporation (NASDAQ:QDEL)
Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 89.24%
Insider Trades by Quarter for Quidel Corporation (NASDAQ:QDEL)
Institutional Ownership by Quarter for Quidel Corporation (NASDAQ:QDEL)
Insider Trades by Quarter for Quidel Corporation (NASDAQ:QDEL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2017Douglas C BryantCEOSell36,000$24.98$899,280.00View SEC Filing  
5/30/2017Douglas C BryantCEOSell12,000$25.10$301,200.00View SEC Filing  
5/26/2017Douglas C BryantCEOSell12,000$24.90$298,800.00View SEC Filing  
5/2/2017Robert Joseph BujarskiSVPSell43,225$24.27$1,049,070.75View SEC Filing  
5/1/2017Robert Joseph BujarskiSVPSell33,225$24.20$804,045.00View SEC Filing  
4/28/2017Douglas C BryantCEOSell36,000$24.16$869,760.00View SEC Filing  
3/31/2017Douglas C BryantCEOSell37,080$22.50$834,300.00View SEC Filing  
2/28/2017Douglas C. BryantCEOSell106,920$21.39$2,287,018.80View SEC Filing  
12/1/2016Robert Joseph BujarskiSVPSell60,000$22.84$1,370,400.00View SEC Filing  
11/30/2016Douglas C BryantCEOSell72,000$22.89$1,648,080.00View SEC Filing  
11/29/2016Douglas C BryantCEOSell24,000$22.84$548,160.00View SEC Filing  
11/28/2016Douglas C BryantCEOSell24,000$23.02$552,480.00View SEC Filing  
11/25/2016John TameriusSVPSell8,878$23.50$208,633.00View SEC Filing  
9/30/2016Douglas C BryantCEOSell69,168$21.76$1,505,095.68View SEC Filing  
8/30/2016Douglas C BryantCEOSell2,832$22.00$62,304.00View SEC Filing  
8/9/2016Robert Joseph BujarskiSVPSell22,057$22.58$498,047.06View SEC Filing  
8/1/2016John TameriusSVPSell7,000$23.02$161,140.00View SEC Filing  
2/19/2016Douglas C. BryantCEOBuy3,700$13.91$51,467.00View SEC Filing  
12/2/2015John TameriusSVPSell21,109$21.95$463,342.55View SEC Filing  
10/30/2015Douglas C BryantCEOBuy20,000$19.76$395,200.00View SEC Filing  
10/3/2014John TameriusSVPSell5,000$28.00$140,000.00View SEC Filing  
9/18/2014John TameriusSVPSell10,000$26.50$265,000.00View SEC Filing  
7/24/2014Douglas C BryantCEOBuy20,000$24.12$482,400.00View SEC Filing  
7/23/2014John TameriusSVPSell15,000$24.50$367,500.00View SEC Filing  
6/24/2014John TameriusSVPSell5,000$23.06$115,300.00View SEC Filing  
2/26/2014John TameriusSVPSell47,246$27.69$1,308,241.74View SEC Filing  
2/13/2014Rodney DammeyerDirectorSell26,000$27.70$720,200.00View SEC Filing  
10/29/2013Mark PulidoDirectorSell12,750$25.31$322,702.50View SEC Filing  
5/29/2013Robert Joseph BujarskiSVPSell28,808$23.16$667,193.28View SEC Filing  
5/17/2013Robert Joseph BujarskiSVPSell27,479$23.12$635,314.48View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Quidel Corporation (NASDAQ:QDEL)
Latest Headlines for Quidel Corporation (NASDAQ:QDEL)
Source:
DateHeadline
finance.yahoo.com logoQuidel’s Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®’s 2017 Good Design Awards®
finance.yahoo.com - June 23 at 9:22 AM
americanbankingnews.com logo Brokerages Anticipate Quidel Corporation (QDEL) Will Post Quarterly Sales of $42.17 Million
www.americanbankingnews.com - June 17 at 8:46 AM
americanbankingnews.com logo-$0.17 EPS Expected for Quidel Corporation (QDEL) This Quarter
www.americanbankingnews.com - June 15 at 6:28 PM
americanbankingnews.com logoOxford Immunotec Global PLC (OXFD) & Quidel Corporation (QDEL) Head to Head Contrast
www.americanbankingnews.com - June 13 at 8:16 PM
americanbankingnews.com logoIDEXX Laboratories (IDXX) & Quidel Corporation (QDEL) Financial Comparison
www.americanbankingnews.com - June 13 at 4:49 PM
americanbankingnews.com logoQuidel Corporation (QDEL) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 12 at 8:48 AM
finance.yahoo.com logoQuidel Receives the CE Mark for Its Thyretain® TBI Reporter BioAssay
finance.yahoo.com - June 8 at 12:23 AM
americanbankingnews.com logoReviewing Trinity Biotech plc (TRIB) and Quidel (QDEL)
www.americanbankingnews.com - June 5 at 4:10 PM
americanbankingnews.com logoInsider Selling: Quidel Co. (QDEL) CEO Sells 12,000 Shares of Stock
www.americanbankingnews.com - May 31 at 10:28 PM
americanbankingnews.com logoQuidel Co. (QDEL) CEO Sells $899,280.00 in Stock
www.americanbankingnews.com - May 31 at 10:26 PM
finance.yahoo.com logoQuidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay
finance.yahoo.com - May 30 at 7:05 PM
seekingalpha.com logoFDA OKs Quidel's flu test for Sofia analyzer; shares up 2%
seekingalpha.com - May 30 at 4:17 PM
finance.yahoo.com logoQuidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay
finance.yahoo.com - May 25 at 5:47 AM
finance.yahoo.com logoETFs with exposure to Quidel Corp. : May 18, 2017
finance.yahoo.com - May 19 at 12:16 PM
americanbankingnews.com logoQuidel's (QDEL) "Hold" Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - May 19 at 10:52 AM
seekingalpha.com logoQuidel closes $14M acquisition of eye health diagnostic products
seekingalpha.com - May 16 at 7:49 PM
finance.yahoo.com logoQuidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses
finance.yahoo.com - May 16 at 7:07 PM
americanbankingnews.com logoQuidel Co. (QDEL) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - May 16 at 9:00 AM
finance.yahoo.com logoQuidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Clostridium difficile (C. difficile) Infections
finance.yahoo.com - May 11 at 7:52 PM
americanbankingnews.com logoInsider Selling: Quidel Co. (QDEL) SVP Sells 33,225 Shares of Stock
www.americanbankingnews.com - May 4 at 1:09 AM
americanbankingnews.com logoQuidel Co. (QDEL) SVP Sells $1,049,070.75 in Stock
www.americanbankingnews.com - May 4 at 1:04 AM
americanbankingnews.com logoQuidel (QDEL) Receiving Somewhat Favorable News Coverage, Study Shows
www.americanbankingnews.com - May 3 at 1:11 AM
finance.yahoo.com logoETFs with exposure to Quidel Corp. : May 2, 2017
finance.yahoo.com - May 2 at 5:13 PM
finance.yahoo.com logoQuidel Corp. :QDEL-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 6:44 PM
finance.yahoo.com logoQuidel to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
finance.yahoo.com - May 1 at 6:44 PM
americanbankingnews.com logoZacks: Analysts Expect Quidel Co. (QDEL) Will Announce Quarterly Sales of $42.17 Million
www.americanbankingnews.com - April 29 at 8:01 AM
americanbankingnews.com logoQuidel Co. (QDEL) CEO Douglas C. Bryant Sells 36,000 Shares
www.americanbankingnews.com - April 29 at 1:29 AM
americanbankingnews.com logoQuidel (QDEL) Earning Positive Press Coverage, Report Shows
www.americanbankingnews.com - April 28 at 11:10 PM
americanbankingnews.com logoQuidel Co. (QDEL) Expected to Post Earnings of -$0.17 Per Share
www.americanbankingnews.com - April 27 at 11:22 PM
americanbankingnews.com logoPositive Press Coverage Likely to Affect Quidel (QDEL) Stock Price
www.americanbankingnews.com - April 25 at 5:54 PM
finance.yahoo.com logoEdited Transcript of QDEL earnings conference call or presentation 24-Apr-17 9:00pm GMT
finance.yahoo.com - April 25 at 10:18 AM
americanbankingnews.com logoQuidel Co. (QDEL) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - April 25 at 9:56 AM
americanbankingnews.com logoQuidel Co. (QDEL) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS
www.americanbankingnews.com - April 24 at 10:08 PM
finance.yahoo.com logoQuidel Reports First Quarter 2017 Financial Results
finance.yahoo.com - April 24 at 5:54 PM
marketbeat.com logoQuidel posts 1Q profit
marketbeat.com - April 24 at 5:16 PM
americanbankingnews.com logoQuidel Co. (QDEL) Rating Increased to C- at TheStreet
www.americanbankingnews.com - April 21 at 3:47 PM
americanbankingnews.com logoQuidel (QDEL) Getting Favorable Media Coverage, Analysis Finds
www.americanbankingnews.com - April 15 at 4:51 PM
americanbankingnews.com logoQuidel Co. (QDEL) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 12 at 7:28 AM
finance.yahoo.com logoQuidel to Hold First Quarter 2017 Financial Results Conference Call on April 24, 2017
finance.yahoo.com - April 11 at 7:13 PM
americanbankingnews.com logoZacks: Brokerages Expect Quidel Co. (QDEL) Will Announce Quarterly Sales of $59.58 Million
www.americanbankingnews.com - April 8 at 9:07 AM
americanbankingnews.com logo$0.14 EPS Expected for Quidel Co. (QDEL) This Quarter
www.americanbankingnews.com - April 6 at 4:19 PM
finance.yahoo.com logo5 Stocks with Solid Efficiency Ratio to Buy in April
finance.yahoo.com - April 3 at 9:02 AM
americanbankingnews.com logoQuidel Co. (QDEL) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - March 27 at 1:28 PM
americanbankingnews.com logoQuidel Co. (QDEL) Upgraded by Zacks Investment Research to “Strong-Buy”
www.americanbankingnews.com - March 20 at 9:55 AM
biz.yahoo.com logoQUIDEL CORP /DE/ Files SEC form 8-K, Regulation FD Disclosure
biz.yahoo.com - March 13 at 7:07 PM
finance.yahoo.com logoQuidel to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 2 at 7:33 PM
biz.yahoo.com logoQUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 1 at 1:20 PM
finance.yahoo.com logoQUIDEL CORP /DE/ Financials
finance.yahoo.com - February 22 at 7:33 PM
biz.yahoo.com logoQUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - February 21 at 5:25 PM
us.rd.yahoo.com logoCoverage initiated on Quidel by CL King
us.rd.yahoo.com - February 18 at 8:11 AM

Social

Chart

Quidel Corporation (QDEL) Chart for Wednesday, June, 28, 2017

This page was last updated on 6/28/2017 by MarketBeat.com Staff